A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT01691846
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01691846
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Argentina, Mexico
- Registry status
- Completed
Technical summary
Registry record NCT01691846. Randomized; double masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2013-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
- Condition
- Diabetes Mellitus Type 2
- Intervention (Drug)
- aleglitazar+metformin
- Intervention (Drug)
- placebo+metformin
- Lead sponsor
- Hoffmann-La Roche
Record details
- Record id
cardio:ct-nct01691846- Content hash
5f98403db1238e4191c9c7f95e646835b81af83850c4e0551e3c9b4a301b6493